CONTACT YOUR POLICYMAKERS
Email your governor and state Medicaid director today urging them to commit to lifting these barriers for Medicaid beneficiaries to eliminate hepatitis C.
State Medicaid programs have removed
prior authorization on HCV treatment, one of the most stubborn barriers blocking access to care for millions of Americans.until the WHOs 2030 target for global viral hepatitis elimination.
As of August 2023, the following 25 states have removed prior authorization for most patients: Alaska, Arizona, California, Colorado, Delaware, District of Columbia, Florida, Hawaii, Idaho, Illinois, Indiana, Louisiana, Massachusetts, Michigan, Missouri, New Hampshire, New York, Oklahoma, Oregon, Pennsylvania, Rhode Island, Texas, Virginia, Washington, Wisconsin.
The above grades reflect our most up-to-date assessment of Medicaid recipients’ ability to access HCV treatment in jurisdictions across the country. For a more detailed breakdown of our assessment criteria, check out our comprehensive rubric or complete state-by-state assessments.
Citation: Center for Health Law and Policy Innovation & National Viral Hepatitis Roundtable, Hepatitis C: State of Medicaid Access (2023), www.stateofhepc.org
Washington, D.C. (August 31, 2023) – The Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) and the National Viral Hepatitis Roundtable (NVHR) today published updates to… [Read More]
FOR IMMEDIATE RELEASE WASHINGTON, D.C. (June 30, 2023) – In response to disturbing new data released by the Centers for Disease Control and Prevention (CDC), the Center for Health Law… [Read More]
FOR IMMEDIATE RELEASE WASHINGTON, D.C. (June 12, 2023) – The Center for Health Law & Policy Innovation (CHLPI) of Harvard Law School and the National Viral Hepatitis Roundtable (NVHR) today… [Read More]
Email your governor and state Medicaid director today urging them to commit to lifting these barriers for Medicaid beneficiaries to eliminate hepatitis C.
Access our infographics, social media toolkit and digital resources.
Join the NVHR Voices4Hep network to connect with advocates across the country pushing for policies that eliminate hepatitis C by 2030.
@2023 HEPATITIS C: STATE OF MEDICAID ACCESS
As of August 2023, 25 states have removed prior authorization for most patients: AK, AR, CA, CO, DC, DE, FL, HI, ID, IL, IN, LA, MA, MI, MO, NH, NY, OK, OR, PA, RI, TX, VA, WA, WI.